Skip to Content

Cipla 423 50 mg (Celecoxib 50 mg)

Pill with imprint Cipla 423 50 mg is White, Capsule-shape and has been identified as Celecoxib 50 mg. It is supplied by Cipla USA Inc..

Celecoxib is used in the treatment of osteoarthritis; ankylosing spondylitis; familial adenomatous polyposis; juvenile rheumatoid arthritis; migraine and belongs to the drug class cox-2 inhibitors. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 423 50 mg

Celecoxib 50 mg Cipla 423 50 mg

Celecoxib

Imprint
Cipla 423 50 mg
Strength
50 mg
Color
White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0423
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone, sodium lauryl sulfate, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.